Skip to content

Zymeworks ZYME Accounts Payable

Accounts Payable at other companies

Pfizer logo
PfizerPFE
$4.51B-14.0%
Amgen logo
AmgenAMGN
$2.94B+22.0%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$7.52M+22.8%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$13.31M+243%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$20.81M-36.6%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$6.84M+213%

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%
P/S21.6×+13.2×

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's accounts payable?
Zymeworks (ZYME) reported accounts payable of $30.23M in Q1 2026.
How has Zymeworks's accounts payable changed year-over-year?
Zymeworks's accounts payable increased by 478.7% year-over-year, from $5.22M to $30.23M.
What is the long-term trend for Zymeworks's accounts payable?
Over 4 years (2021 to 2025), Zymeworks's accounts payable has grown at a 62.8% compound annual growth rate (CAGR), from $5.17M to $36.35M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.